Massimo Maffei

Title: Massimo Maffei: Innovator in Vaccine Stability

Introduction

Massimo Maffei, an accomplished inventor based in Siena, Italy, has made significant contributions to the field of vaccine development. With a portfolio of three patents, he is particularly recognized for his innovative approaches to enhance the stability and efficacy of vaccines.

Latest Patents

Among his notable inventions is a patent focused on vaccines comprising aluminum adjuvants and histidine. This invention aims to improve the stability of vaccines containing aluminum salts by incorporating the amino acid histidine. His method enhances pH stability and adjuvant adsorption while reducing antigen hydrolysis. Histidine is ideally used during the adsorption process to aluminum salts. The targeted antigens in these vaccines can be proteins or saccharides, with a preference for those derived from *Neisseria meningitidis*.

Career Highlights

Massimo Maffei's professional journey has seen him serve at prominent companies in the pharmaceutical and vaccine sectors, including Novartis Vaccines and Diagnostics and Novartis Vaccines and Diagnostics Srl. His work at these institutions has played a crucial role in advancing vaccine technologies.

Collaborations

Throughout his career, Massimo has collaborated with professionals like Mario Contorni, contributing to the collective effort in developing groundbreaking vaccine solutions.

Conclusion

Massimo Maffei continues to drive innovation in the vaccine industry, focusing on improving stability and effectiveness. His work exemplifies the importance of advancements in vaccine technology, addressing public health challenges with innovative inventions.